-
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study2022 Blood article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
Michael H. Albert, Tiarlan Sirait, Dirk‐Jan Eikema, Katerina Bakunina, Claudia Wehr, Felipe Suárez, +63 more
56citations -
External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails2020 Blood article Immunology and Microbiology Immune Cell Function and Interaction Open access cited by 3 patents
Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Carolin Massalski, Sandra Kay Frank, Jürgen Sauter, +16 more
55citations -
Apollo: Phase 3 Randomized Study of Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Meletios Athanasios Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, +17 more
51citations -
Complement activation drives antibody-mediated transfusion-related acute lung injury via macrophage trafficking and formation of NETs2023 Blood article Immunology and Microbiology Complement system in diseases Open access cited by 1 patent
Saskia van der Velden, Thijs L. J. van Osch, Amina Seghier, Arthur E. H. Bentlage, Juk Yee Mok, Dionne M. Geerdes, +9 more
51citations -
Efficacy and Safety of Less Frequent/Lower Intensity Dosing of Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study
Ajai Chari, Albert Oriol, Amrita Y. Krishnan, Maria Del Carmen Martinez Chamorro, Luciano J. Costa, María‐Victoria Mateos, +9 more
50citations -
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency2020 Blood article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
Francesco Saettini, M. Cecilia Poli, Jaime E. Vengoechea, Sonia Bonanomi, Julio César Orellana, Grazia Fazio, +28 more
49citations -
Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation2020 Blood article Biochemistry, Genetics and Molecular Biology Genetic Associations and Epidemiology Open access cited by 2 patents
Louisa Goumidi, Florian Thibord, Kerri L. Wiggins, Ruifang Li‐Gao, Mickael R. Brown, Astrid van Hylckama Vlieg, +22 more
48citations -
Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome2021 Blood article Medicine Cutaneous lymphoproliferative disorders research Open access cited by 1 patent
Safa Najidh, Cornelis P. Tensen, Alita J. van der Sluijs‐Gelling, Cristina Teodósio, Davy Cats, Hailiang Mei, +8 more
47citations -
Phase 2 Study of Teclistamab-Based Induction Regimens in Patients with Transplant-Eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the GMMG-HD10/DSMM-XX (MajesTEC-5) Trial
Marc Steffen Raab, Niels Weinhold, Klaus Martin Kortüm, Jan Krönke, Lilli Podola, Uta Bertsch, +23 more
47citations -
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
Gerald Illerhaus, Andrés J.M. Ferreri, Mascha Binder, Peter Borchmann, Justin Hasenkamp, Stephan Stilgenbauer, +43 more
44citations -
In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Lutz Peter Mueller, Schmid Christoph, Stefan W. Krause, +22 more
42citations -
The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia2023 Blood article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Marja Hakkarainen, Ilse Kaaja, Suvi P. M. Douglas, Thomas J. Vulliamy, Inderjeet S Dokal, Jean Pierre Soulier, +23 more
42citations -
Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis2023 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Naveen Pemmaraju, Adam J. Mead, Tim C. P. Somervaille, James K. McCloskey, Francesca Palandri, Steffen Koschmieder, +18 more
42citations -
Impaired adhesion of neutrophils expressing Slc44a2/HNA-3b to VWF protects against NETosis under venous shear rates2021 Blood article Immunology and Microbiology Neutrophil, Myeloperoxidase and Oxidative Mechanisms Open access
Gaïa Zirka, Philippe Robert, Julia Tilburg, Victoria Tishkova, Chrissta X. Maracle, Paulette Legendre, +5 more
36citations -
Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
Hartmut Goldschmidt, Eva Nievergall, Roland R. Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, +25 more
33citations -
Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT2022 Blood article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access
Catharina Schuetz, Markus Johannes Ege, Jolan Eszter Walter, Maaike Kusters, Austen J. J. Worth, Jennifer Ann Kanakry, +34 more
32citations